Lieff Cabraser Heimann & Bernstein, LLP
Elizabeth Cabraser is a founding partner of Lieff Cabraser Heimann & Bernstein, LLP, a plaintiffs’ litigation firm with offices in San Francisco, New York, Nashville, and Munich. Possessing unparalleled expertise in complex civil litigation, Elizabeth has served as court‐appointed lead, co‐lead, or class counsel in scores of federal multi‐district and state coordinated proceedings. These cases include multi‐state Tobacco, the Exxon Valdez disaster, Breast Implants, Fen‐Phen (Diet Drugs), Vioxx, Toyota sudden acceleration, the Volkswagen “Clean Diesel” and Fiat Chrysler Ecodiesel Emissions MDLs, numerous securities/investment fraud cases, and Holocaust litigation. Today, Elizabeth serves in court‐appointed leadership positions in several of the nation’s highest profile civil cases, including serving as a Co‐Lead Counsel in the Camp Lejeune Water Litigation. In January 2018, she was appointed to the Plaintiffs’ Executive Committee and Settlement Negotiating Committee in the National Prescription Opiates MDL, and serves as Plaintiffs’ Lead Counsel in the McKinsey & Co. National Prescription Opiate MDL.
Elizabeth has been repeatedly recognized as one of the foremost litigators in the U.S., and was selected an unprecedented four times as one of the 100 Most Influential Lawyers in America by the National Law Journal, which has called her “a pillar of the plaintiffs’ bar.”
She received a J.D. from the University of California, Berkeley, School of Law (Berkeley Law), Berkeley, California and A.B. from University of California, Berkeley, California. She regularly teaches Aggregate Litigation and Multidistrict Litigation course at Yale and Berkeley Law Schools.
